Age-Related Macular Degeneration: Classification and Pathogenesis

Age-related macular degeneration (AMD) was first described in 1885 by Otto Haab as a disease in patients above 50 years of age with progressive retinal pigment epithelial and atrophic degenerations of the macula reducing the central visual acuity. AMD is a neurodegenerative disease and is now the...

Full description

Bibliographic Details
Published in:	Türk Oftalmoloji Dergisi
Main Author:	İmren Akkoyun
Format:	Article
Language:	English
Published:	Turkish Ophthalmology Society 2014-12-01
Subjects:	AMD geographic atrophy neovascular AMD pathogenesis
Online Access:	http://www.oftalmoloji.org/article_7551/Age-related-Macular-Degeneration-Classification-And-Pathogenesis

Similar Items

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
by: Eleonora M. Lad, et al.
Published: (2023-09-01)

The role of peripheral blood microRNAs in the pathogenesis and treatment response of age-related macular degeneration
by: Meng Kong, et al.
Published: (2025-12-01)

Genetic Insights into Age-Related Macular Degeneration
by: Bhumika, et al.
Published: (2024-07-01)

Treatment of age related macular degeneration (AMD) currently and in the past
by: Klaudia Brożyna, et al.
Published: (2018-08-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
by: Kiruthika M, et al.
Published: (2025-02-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
by: M. M. Bikbov, et al.
Published: (2022-03-01)

Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
by: H. Mhmud, et al.
Published: (2025-06-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
by: Răzvan Vasile ROPCIUC
Published: (2024-05-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
by: Julia Nguyen, et al.
Published: (2024-02-01)

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium
by: Carmen A. Puliafito, et al.
Published: (2020-05-01)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
by: Varsha Pramil, et al.
Published: (2021-10-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
by: Niloofar Piri, et al.
Published: (2023-05-01)

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
by: Treefa Shwani, et al.
Published: (2023-11-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
by: Deepali R Damkondwar, et al.
Published: (2022-01-01)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
by: Tan CS, et al.
Published: (2022-03-01)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
by: Razi F, et al.
Published: (2016-02-01)

Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study
by: Deependra Vikram Singh, et al.
Published: (2024-12-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
by: Grace A. Borchert, et al.
Published: (2023-08-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
by: Sonali Nashine
Published: (2021-09-01)

Exploiting Microperimetry as a Functional End Point in Healthy Aging and Different Stages of Age-Related Macular Degeneration
by: Johannes Schrittwieser, MD, et al.
Published: (2025-11-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Subretinal Drug Delivery in Wet Age Related Macular Degeneration with Sub-macular Hemorrhage
by: Atul Kumar, et al.
Published: (2014-10-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: João Estarreja, et al.
Published: (2024-07-01)

Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
by: Lucia Finocchio, et al.
Published: (2023-12-01)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
by: Tony Wu, et al.
Published: (2023-10-01)

Seg-Swin: A Dual-Attention Transformer Model for Advanced AMD Classification and Lesion Detection Using Color Fundus Imaging
by: Niveen Nasr El-Den, et al.
Published: (2025-01-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
by: Yujong Yi, et al.
Published: (2024-03-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
by: Audrey Yan, et al.
Published: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
by: Mayank Choubey, et al.
Published: (2023-11-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
by: Anat Loewenstein, et al.
Published: (2024-12-01)

Age-related macular degeneration: prevention and treatment. A review
by: K. A. Mirzabekova
Published: (2014-07-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Association of Age-Related Macular Degeneration with Cholelithiasis
by: Kevin R. Zhang, MD, PhD, et al.
Published: (2025-07-01)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
by: Praveen Yerramothu
Published: (2018-07-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
by: Ines Lains, MD, PhD, et al.
Published: (2024-01-01)

Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: a retrospective OCT-angiography study
by: Marco Lombardo, et al.
Published: (2025-10-01)

Outcomes of Anti-VEGF Therapy in Eyes with Diabetic Macular Edema, Vein Occlusion-Related Macular Edema, and Neovascular Age-Related Macular Degeneration: A Systematic Review
by: Aldokhail LS, et al.
Published: (2024-12-01)

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
by: Eloi Debourdeau, et al.
Published: (2024-07-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
by: Ngoc Thien Le, et al.
Published: (2023-12-01)